TABLE 1.
Characteristics of study population
| All | Healthy controls | Asymptomatic(n = 63) | Mild(n = 51) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aa(NAT + IgG−IgM−) | Ab(NAT + IgG + IgM−) | Ac(NAT−IgG + IgM−) | Ad(NAT−IgG + IgM+) | Ma(NAT + IgG−IgM−) | Mb(NAT + IgG + IgM−) | Mc(NAT + IgG + IgM+) | Md(NAT−IgG + IgM−) | Me(NAT−IgG + IgM+) | |||
| N | 177 | 63 | 4 | 8 | 28 | 23 | 6 | 10 | 22 | 4 | 9 |
| Age, years | |||||||||||
| Mean(SD) | 44.6(19.25) | 43.2(19.85) | 42.8(8.62) | 40.6(10.85) | 46.5(18.05) | 44.7(17.89) | 39.7(25.02) | 39.7(23.77) | 47.6(22.46) | 45.0(31.12) | 54.0(7.40) |
| Median(IQR) | 46(30‐59) | 46(27‐60) | 41(36‐50) | 38(31‐52) | 50(29‐58) | 40(29‐55) | 38(29‐46) | 32(20‐58) | 51(30‐64) | 56(25‐66) | 55(48‐59) |
| Sex, n(%) | |||||||||||
| Male | 85(48.0) | 33(52.4) | 0(0.0) | 2(25.0) | 13(46.4) | 10(43.5) | 3(50.0) | 6(60.0) | 11(50.0) | 3(75.0) | 4(44.4) |
| Female | 92(52.0) | 30(47.6) | 4(100.0) | 6(75.0) | 15(53.6) | 13(56.5) | 3(50.0) | 4(40.0) | 11(50.0) | 1(25.0) | 5(55.6) |
Abbreviations: IQR, interquartile range; SD, standard deviation.